News & Trends - Medical Technology

Private hospitals’ high quality care recognised at APHA awards

Health Industry Hub | February 18, 2020 |
[Total: 1    Average: 4/5]

A palliative care service offering patients support to die at home, a driving service that gets patients to and from their dialysis appointments and a mental health support program are all finalists in the APHA Awards For Excellence.

The Awards, to be presented at this year’s APHA 39th National Congress (APHA Congress) gala dinner, celebrate private hospital’s achievements in three categories: Clinical excellence, comprehensive care and consumer partnerships.

Australian Private Hospitals Association (APHA) CEO Michael Roff said the awards were developed to recognise the high quality of care Australians receive from private hospitals.

“The diversity in the entries for each category highlights the scope of care private hospitals provide. These are all innovative programs designed to improve patient’s experience and improve care or access to care,” he said.

Mr Roff said one of the great things to come out of these programs are the additional unintended benefits for patients.

“The Epworth Eastern’s program of volunteers driving renal dialysis patients to their appointments and home again has not only made it easier for patients to get care, but also created new friendships and broken the social isolation that often comes from having a serious illness and challenges in accessing transport.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

“Another is South Australia’s St Andrew’s Hospital’s critical bleeding working group, a program set up to improve timely administration of blood for patients requiring massive transfusions. Not only has this led to reduced wastage of blood products but the group also developed a purpose-built Massive Transfusion Shipper now used by the South Australian Ambulance Service.

“These programs illustrate the patient-focus of our private hospitals, and it is important to celebrate those successes,” he said.

Attendees at the APHA Congress will have a role to play in determining the winners. Finalists will present their work during a session at the APHA Congress and delegates will vote for the best entries. The delegate vote accounts for five percent of the final score.

Winners will be announced on Monday 16 March 2020 in Adelaide.

Awards finalists

Clinical excellence – quality of care and patient outcomes

  • Sydney Adventist Hospital: San community palliative care service
  • Ramsay Health Care: Ramsay national mental health programs
  • St Andrews Hospital: Critical bleeding working group

Comprehensive care

  • Epworth Eastern: Renal dialysis patient transport vehicle program
  • Friendly Society Private Hospital: Culture of accountability

Consumer partnerships

  • Bethesda Health Care: Consumer partnership committee
  • Westmead Private Hospital: Luxury maternity unit

Suppliers & Service Providers: Enhance business visibility, differentiate your brand and maximise your reach. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Discover our unique digital media solutions with superior open rates and click through rates.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

First immunotherapy PBS listed in small cell lung cancer - Pharma News

First immunotherapy treatment PBS listed in small cell lung cancer

Health Industry Hub | February 19, 2020 |

Pharma News: Effective 1 March 2020 the first immunotherapy treatment for small cell lung cancer (SCLC) will be available on […]


News & Trends - Medical Technology

Blood test to improve ovarian cancer diagnosis - MedTech News

Blood test to improve ovarian cancer diagnosis

Health Industry Hub | February 19, 2020 |

MedTech News: Australian researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis […]



The largest healthcare event in the region - Australian Healthcare Week - Medical News

Don’t miss the largest healthcare event in the region – Australian Healthcare Week

Health Industry Hub | February 19, 2020 |

Health Industry Hub is proud to partner with and support the free-to-attend 10th Annual Australian Healthcare Week Expo, held March […]


News & Trends - Pharmaceuticals

BMS announces new 5-year data in advanced renal cell carcinoma - Pharma News

BMS announces new 5-year data in advanced renal cell carcinoma

Health Industry Hub | February 19, 2020 |

Pharma News: Bristol-Myers Squibb announced five-year follow-up study results demonstrating that Opdivo (nivolumab) treatment delivers superior overall survival (OS) and […]